Mark Bezjak on corporate leadership
From Zimmer Biomet: In Studio with Mark Bezjak, Joe Urban, and Joe Mullings · · Mullings Group
“It started with leadership and the bold statement of being the boldest Medtech company on the planet; we knew 20% of total joints were problematic and nobody answered why, and understanding why drove innovation from the very top down.”
On , Mark Bezjak, President of Americas at Zimmer Biomet, spoke about corporate leadership during Zimmer Biomet: In Studio with Mark Bezjak, Joe Urban, and Joe Mullings on Mullings Group.
About Mark Bezjak
Mark Bezjak, President of Americas at Zimmer Biomet, appeared on a December 2024 episode of "160 Studios" hosted by Joe Mullings. During the interview, Bezjak discussed his 16-year tenure at the company, attributing his longevity to the opportunity to "differentiate musculoskeletal care" and the people and leadership at the organization. He stated that he took his current role because of CEO Ivon, citing the need to "work at that pace" and "think creatively and outside the box" to change the delivery of musculoskeletal care. Bezjak described the company's focus on advancing technology, including its PIQ platform for collecting post-operative data, and predicted a "seismic shift" in orthopedics over the next 24 to 36 months with the integration of sensored technology, interconnectivity, and predictive analytics. Bezjak noted that 20% of knee replacement patients are not satisfied with their outcomes, and he said the company's innovation is driven by understanding the patient journey from pre-operative care through rehab. He emphasized Zimmer Biomet's goal of being "the boldest medtech company" and its shift from a focus on metal and plastic implants to a solutions-based organization. Bezjak also highlighted the company's partnerships in building ambulatory surgery centers and its ability to hyperfocus on musculoskeletal health as an efficiency advantage over competitors.